<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02587520</url>
  </required_header>
  <id_info>
    <org_study_id>ADC01</org_study_id>
    <secondary_id>U1111-1161-3027</secondary_id>
    <nct_id>NCT02587520</nct_id>
  </id_info>
  <brief_title>Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects</brief_title>
  <official_title>Safety and Immunogenicity of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (SP0173) in Healthy Adolescents, Adults, and Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sanofi Pasteur, a Sanofi Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sanofi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This was a dose and formulation ranging study to assess the safety and immunogenicity of
      SP0173 in healthy adolescents, adults, and older adults in the United States (US).

      Primary Objective

        -  To describe the safety profile of each SP0173 investigational formulation.

      Observational Objective:

        -  To describe the immunogenicity of each SP0173 investigational formulation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants received a single dose of vaccine, and were assessed for immunogenicity at
      baseline (pre-vaccination) and at 30 days post-vaccination. They were also monitored for
      safety from day of vaccination up to Day 180 post-vaccination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 22, 2015</start_date>
  <completion_date type="Actual">February 21, 2017</completion_date>
  <primary_completion_date type="Actual">February 21, 2017</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 10-18 Years</measure>
    <time_frame>Within 7 days after vaccination</time_frame>
    <description>A solicited reaction (SR) is an adverse event (AE) that is prelisted in the electronic Case Report Form (eCRF) and considered to be related to vaccination. An SR is therefore an adverse drug reaction (ADR) observed and reported under the conditions (nature &amp; onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and solicited systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 19-64 Years</measure>
    <time_frame>Within 7 days after vaccination</time_frame>
    <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged &gt;=65 Years</measure>
    <time_frame>Within 7 days after vaccination</time_frame>
    <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
  </primary_outcome>
  <number_of_arms>18</number_of_arms>
  <enrollment type="Actual">1363</enrollment>
  <condition>Tetanus</condition>
  <condition>Diphtheria</condition>
  <condition>Pertussis</condition>
  <condition>Whooping Cough</condition>
  <arm_group>
    <arm_group_label>Adolescents: SP0173 Formulation 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 10-18 years received a single dose of the SP0173 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap) vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents: SP0173 Formulation 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 10-18 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents: SP0173 Formulation 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 10-18 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents: SP0173 Formulation 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 10-18 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents: Adacel®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged 10-18 years received Adacel®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adolescents: Boostrix®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged 10-18 years received Boostrix®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: SP0173 Formulation 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 19-64 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: SP0173 Formulation 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 19-64 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: SP0173 Formulation 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 19-64 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: SP0173 Formulation 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged 19-64 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: Adacel®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged 19-64 years received Adacel®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Adults: Boostrix®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged 19-64 years received Boostrix®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: SP0173 Formulation 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged greater than equal to (&gt;=65) years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: SP0173 Formulation 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: SP0173 Formulation 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: SP0173 Formulation 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy participants aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: Adacel®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged &gt;=65 years received Adacel®.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Older Adults: Boostrix®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy participants aged &gt;=65 years received Boostrix®.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed Formulation 1</intervention_name>
    <description>0.5 milliliter (mL), Intramuscular</description>
    <arm_group_label>Adolescents: SP0173 Formulation 1</arm_group_label>
    <arm_group_label>Adults: SP0173 Formulation 1</arm_group_label>
    <arm_group_label>Older Adults: SP0173 Formulation 1</arm_group_label>
    <other_name>SP0173</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 2</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Adolescents: SP0173 Formulation 2</arm_group_label>
    <arm_group_label>Adults: SP0173 Formulation 2</arm_group_label>
    <arm_group_label>Older Adults: SP0173 Formulation 2</arm_group_label>
    <other_name>SP0173</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 3</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Adolescents: SP0173 Formulation 3</arm_group_label>
    <arm_group_label>Adults: SP0173 Formulation 3</arm_group_label>
    <arm_group_label>Older Adults: SP0173 Formulation 3</arm_group_label>
    <other_name>SP0173</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed, Formulation 4</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Adolescents: SP0173 Formulation 4</arm_group_label>
    <arm_group_label>Adults: SP0173 Formulation 4</arm_group_label>
    <arm_group_label>Older Adults: SP0173 Formulation 4</arm_group_label>
    <other_name>SP0173</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Adolescents: Adacel®</arm_group_label>
    <arm_group_label>Adults: Adacel®</arm_group_label>
    <arm_group_label>Older Adults: Adacel®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Licensed Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine</intervention_name>
    <description>0.5 mL, Intramuscular</description>
    <arm_group_label>Adolescents: Boostrix®</arm_group_label>
    <arm_group_label>Adults: Boostrix®</arm_group_label>
    <arm_group_label>Older Adults: Boostrix®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 10 to 18 years, 19 to 64 years, or &gt;= 65 years on the day of inclusion.

          -  Informed consent form had been signed and dated by the participant, or assent form had
             been signed and dated by the participant and informed consent form had been signed and
             dated by the parent/guardian

          -  Participant or participant and parent/guardian able to attend all scheduled visits and
             to comply with all study procedures.

        Exclusion Criteria:

          -  Participant was pregnant, or lactating, or of childbearing potential, (to be
             considered of non-childbearing potential, a female must be premenarche or
             post-menopausal for at least 1 year) surgically sterile, or using an effective method
             of contraception or abstinence from at least 4 weeks prior to vaccination until at
             least 4 weeks after vaccination.

          -  Participation at the time of study enrollment or planned participation during the
             present study period in another clinical trial investigating a vaccine, drug, medical
             device, or medical procedure.

          -  Received any vaccine in the 4 weeks preceding the trial vaccination or planned receipt
             of any vaccine between Visit 1 and Visit 2.

          -  Known or suspected receipt of a tetanus toxoid, reduced diphtheria toxoid, and
             Acellular pertussis (Tdap) vaccine or Tdap-containing vaccine at any point in time, or
             receipt of a tetanus and diphtheria containing vaccine in the preceding 5 years.

          -  Receipt of immune globulins, blood or blood-derived products in the past 3 months.

          -  Known or suspected congenital or acquired immunodeficiency, immunosuppressive therapy
             such as anti-cancer chemotherapy or radiation therapy within the preceding 6 months,
             or long-term systemic corticosteroids therapy.

          -  History of diphtheria, tetanus, or pertussis infection (confirmed either serologically
             or microbiologically).

          -  Known or suspected systemic hypersensitivity to any of the vaccine components or
             history of life-threatening reaction to the study vaccine or a vaccine containing the
             same substances.

          -  Laboratory-confirmed / self-reported thrombocytopenia or bleeding disorder
             contraindicating intramuscular vaccination.

          -  Bleeding disorder, or receipt of anticoagulants in the 3 weeks preceding inclusion,
             contraindicating intramuscular vaccination.

          -  History of encephalopathy (e.g., coma, decreased level of consciousness, or prolonged
             seizures) not attributable to another identifiable cause within 7 days of
             administration of a previous dose of diphtheria and tetanus toxoids and pertussis
             (DTP), or diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine.

          -  Deprived of freedom by an administrative or court order, or in an emergency setting,
             or hospitalized involuntarily.

          -  Current alcohol abuse or drug addiction.

          -  Chronic illness that was at a stage where it might interfere with trial conduct or
             completion.

          -  Moderate or severe acute illness/infection on the day of vaccination or febrile
             illness (temperature &gt;= 100.4°F).

          -  Identified as an Investigator or employee of the Investigator or study center with
             direct involvement in the proposed study, or identified as an immediate family member
             (i.e., parent, spouse, natural or adopted child) of the Investigator or employee with
             direct involvement in the proposed study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Sanofi Pasteur Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>DeLand</city>
        <state>Florida</state>
        <zip>32720</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Meridian</city>
        <state>Idaho</state>
        <zip>83642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bardstown</city>
        <state>Kentucky</state>
        <zip>40004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nicholasville</city>
        <state>Kentucky</state>
        <zip>40356</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Mount Pleasant</city>
        <state>South Carolina</state>
        <zip>29464</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84121</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.sanofipasteur.com</url>
    <description>Related Info</description>
  </link>
  <link>
    <url>http://www.sanofi.com</url>
    <description>Related Info</description>
  </link>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 22, 2015</study_first_submitted>
  <study_first_submitted_qc>October 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2015</study_first_posted>
  <results_first_submitted>February 18, 2020</results_first_submitted>
  <results_first_submitted_qc>February 18, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">March 4, 2020</results_first_posted>
  <disposition_first_submitted>February 19, 2018</disposition_first_submitted>
  <disposition_first_submitted_qc>February 19, 2018</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">February 22, 2018</disposition_first_posted>
  <last_update_submitted>February 18, 2020</last_update_submitted>
  <last_update_submitted_qc>February 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tetanus</keyword>
  <keyword>Diphtheria</keyword>
  <keyword>Pertussis</keyword>
  <keyword>SP0173</keyword>
  <keyword>Tdap vaccine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Whooping Cough</mesh_term>
    <mesh_term>Tetanus</mesh_term>
    <mesh_term>Diphtheria</mesh_term>
    <mesh_term>Tetany</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Qualified researchers may request access to patient level data and related study documents including the clinical study report, study protocol with any amendments, blank case report form, statistical analysis plan, and dataset specifications. Patient level data will be anonymized and study documents will be redacted to protect the privacy of trial participants. Further details on Sanofi's data sharing criteria, eligible studies, and process for requesting access can be found at: https://www.clinicalstudydatarequest.com/.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 13, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT02587520/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 13, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/20/NCT02587520/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Study participants were enrolled in 20 centers in the Unites States (US) from 22 October 2015 to 15 August 2016.</recruitment_details>
      <pre_assignment_details>A total of 1363 participants were randomized in a 1:1:1 ratio to 1 of the 6 formulation study groups. Randomization was stratified by age (adolescents: age 10–18 years, adults: age 19–64 years, and older adults: age greater than equal to [&gt;=] 65 years).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Adolescents: SP0173 Formulation 1</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap) vaccine.</description>
        </group>
        <group group_id="P2">
          <title>Adolescents: SP0173 Formulation 2</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P3">
          <title>Adolescents: SP0173 Formulation 3</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P4">
          <title>Adolescents: SP0173 Formulation 4</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P5">
          <title>Adolescents: Adacel®</title>
          <description>Healthy participants aged 10–18 years received Adacel®.</description>
        </group>
        <group group_id="P6">
          <title>Adolescents: Boostrix®</title>
          <description>Healthy participants aged 10–18 years received Boostrix®.</description>
        </group>
        <group group_id="P7">
          <title>Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P8">
          <title>Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P9">
          <title>Adults: SP0173 Formulation 3</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P10">
          <title>Adults: SP0173 Formulation 4</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P11">
          <title>Adults: Adacel®</title>
          <description>Healthy participants aged 19–64 years received Adacel®.</description>
        </group>
        <group group_id="P12">
          <title>Adults: Boostrix®</title>
          <description>Healthy participants aged 19–64 years received Boostrix®.</description>
        </group>
        <group group_id="P13">
          <title>Older Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P14">
          <title>Older Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P15">
          <title>Older Adults: SP0173 Formulation 3</title>
          <description>Healthy subjects aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P16">
          <title>Older Adults: SP0173 Formulation 4</title>
          <description>Healthy subjects aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="P17">
          <title>Older Adults: Adacel®</title>
          <description>Healthy participants aged &gt;=65 years received Adacel®.</description>
        </group>
        <group group_id="P18">
          <title>Older Adults: Boostrix®</title>
          <description>Healthy participants aged &gt;=65 years received Boostrix®.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
                <participants group_id="P2" count="71"/>
                <participants group_id="P3" count="78"/>
                <participants group_id="P4" count="79"/>
                <participants group_id="P5" count="75"/>
                <participants group_id="P6" count="75"/>
                <participants group_id="P7" count="76"/>
                <participants group_id="P8" count="73"/>
                <participants group_id="P9" count="76"/>
                <participants group_id="P10" count="76"/>
                <participants group_id="P11" count="76"/>
                <participants group_id="P12" count="73"/>
                <participants group_id="P13" count="77"/>
                <participants group_id="P14" count="74"/>
                <participants group_id="P15" count="78"/>
                <participants group_id="P16" count="72"/>
                <participants group_id="P17" count="76"/>
                <participants group_id="P18" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Safety Analysis Set (SafAS)</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="71"/>
                <participants group_id="P3" count="77"/>
                <participants group_id="P4" count="77"/>
                <participants group_id="P5" count="75"/>
                <participants group_id="P6" count="75"/>
                <participants group_id="P7" count="76"/>
                <participants group_id="P8" count="73"/>
                <participants group_id="P9" count="76"/>
                <participants group_id="P10" count="76"/>
                <participants group_id="P11" count="76"/>
                <participants group_id="P12" count="72"/>
                <participants group_id="P13" count="77"/>
                <participants group_id="P14" count="73"/>
                <participants group_id="P15" count="78"/>
                <participants group_id="P16" count="72"/>
                <participants group_id="P17" count="76"/>
                <participants group_id="P18" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="78"/>
                <participants group_id="P2" count="69"/>
                <participants group_id="P3" count="77"/>
                <participants group_id="P4" count="74"/>
                <participants group_id="P5" count="75"/>
                <participants group_id="P6" count="72"/>
                <participants group_id="P7" count="73"/>
                <participants group_id="P8" count="71"/>
                <participants group_id="P9" count="73"/>
                <participants group_id="P10" count="71"/>
                <participants group_id="P11" count="73"/>
                <participants group_id="P12" count="69"/>
                <participants group_id="P13" count="77"/>
                <participants group_id="P14" count="73"/>
                <participants group_id="P15" count="78"/>
                <participants group_id="P16" count="72"/>
                <participants group_id="P17" count="76"/>
                <participants group_id="P18" count="78"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="3"/>
                <participants group_id="P7" count="3"/>
                <participants group_id="P8" count="2"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="5"/>
                <participants group_id="P11" count="3"/>
                <participants group_id="P12" count="4"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="3"/>
                <participants group_id="P10" count="3"/>
                <participants group_id="P11" count="1"/>
                <participants group_id="P12" count="2"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="0"/>
                <participants group_id="P7" count="0"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="1"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="0"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="0"/>
                <participants group_id="P11" count="0"/>
                <participants group_id="P12" count="0"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="1"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="2"/>
                <participants group_id="P5" count="0"/>
                <participants group_id="P6" count="1"/>
                <participants group_id="P7" count="1"/>
                <participants group_id="P8" count="1"/>
                <participants group_id="P9" count="0"/>
                <participants group_id="P10" count="2"/>
                <participants group_id="P11" count="2"/>
                <participants group_id="P12" count="1"/>
                <participants group_id="P13" count="0"/>
                <participants group_id="P14" count="0"/>
                <participants group_id="P15" count="0"/>
                <participants group_id="P16" count="0"/>
                <participants group_id="P17" count="0"/>
                <participants group_id="P18" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Analysis was performed on all randomized participants.</population>
      <group_list>
        <group group_id="B1">
          <title>Adolescents: SP0173 Formulation 1</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap) vaccine.</description>
        </group>
        <group group_id="B2">
          <title>Adolescents: SP0173 Formulation 2</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B3">
          <title>Adolescents: SP0173 Formulation 3</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B4">
          <title>Adolescents: SP0173 Formulation 4</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B5">
          <title>Adolescents: Adacel®</title>
          <description>Healthy participants aged 10–18 years received Adacel®.</description>
        </group>
        <group group_id="B6">
          <title>Adolescents: Boostrix®</title>
          <description>Healthy participants aged 10–18 years received Boostrix®.</description>
        </group>
        <group group_id="B7">
          <title>Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B8">
          <title>Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B9">
          <title>Adults: SP0173 Formulation 3</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B10">
          <title>Adults: SP0173 Formulation 4</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B11">
          <title>Adults: Adacel®</title>
          <description>Healthy participants aged 19–64 years received Adacel®.</description>
        </group>
        <group group_id="B12">
          <title>Adults: Boostrix®</title>
          <description>Healthy participants aged 19–64 years received Boostrix®.</description>
        </group>
        <group group_id="B13">
          <title>Older Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B14">
          <title>Older Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B15">
          <title>Older Adults: SP0173 Formulation 3</title>
          <description>Healthy subjects aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B16">
          <title>Older Adults: SP0173 Formulation 4</title>
          <description>Healthy subjects aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="B17">
          <title>Older Adults: Adacel®</title>
          <description>Healthy participants aged &gt;=65 years received Adacel®.</description>
        </group>
        <group group_id="B18">
          <title>Older Adults: Boostrix®</title>
          <description>Healthy participants aged &gt;=65 years received Boostrix®.</description>
        </group>
        <group group_id="B19">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="80"/>
            <count group_id="B2" value="71"/>
            <count group_id="B3" value="78"/>
            <count group_id="B4" value="79"/>
            <count group_id="B5" value="75"/>
            <count group_id="B6" value="75"/>
            <count group_id="B7" value="76"/>
            <count group_id="B8" value="73"/>
            <count group_id="B9" value="76"/>
            <count group_id="B10" value="76"/>
            <count group_id="B11" value="76"/>
            <count group_id="B12" value="73"/>
            <count group_id="B13" value="77"/>
            <count group_id="B14" value="74"/>
            <count group_id="B15" value="78"/>
            <count group_id="B16" value="72"/>
            <count group_id="B17" value="76"/>
            <count group_id="B18" value="78"/>
            <count group_id="B19" value="1363"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10.8" spread="1.3"/>
                    <measurement group_id="B2" value="11.0" spread="1.3"/>
                    <measurement group_id="B3" value="11.1" spread="1.6"/>
                    <measurement group_id="B4" value="10.8" spread="1.4"/>
                    <measurement group_id="B5" value="10.8" spread="1.5"/>
                    <measurement group_id="B6" value="11.1" spread="1.6"/>
                    <measurement group_id="B7" value="42.5" spread="12.5"/>
                    <measurement group_id="B8" value="41.2" spread="12.1"/>
                    <measurement group_id="B9" value="40.1" spread="12.8"/>
                    <measurement group_id="B10" value="42.1" spread="13.0"/>
                    <measurement group_id="B11" value="41.3" spread="12.7"/>
                    <measurement group_id="B12" value="42.5" spread="13.2"/>
                    <measurement group_id="B13" value="71.3" spread="5.4"/>
                    <measurement group_id="B14" value="71.8" spread="5.4"/>
                    <measurement group_id="B15" value="70.9" spread="4.8"/>
                    <measurement group_id="B16" value="70.8" spread="5.1"/>
                    <measurement group_id="B17" value="70.9" spread="5.0"/>
                    <measurement group_id="B18" value="71.3" spread="4.8"/>
                    <measurement group_id="B19" value="41.2" spread="25.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="35"/>
                    <measurement group_id="B4" value="37"/>
                    <measurement group_id="B5" value="39"/>
                    <measurement group_id="B6" value="40"/>
                    <measurement group_id="B7" value="43"/>
                    <measurement group_id="B8" value="46"/>
                    <measurement group_id="B9" value="38"/>
                    <measurement group_id="B10" value="39"/>
                    <measurement group_id="B11" value="44"/>
                    <measurement group_id="B12" value="36"/>
                    <measurement group_id="B13" value="37"/>
                    <measurement group_id="B14" value="38"/>
                    <measurement group_id="B15" value="51"/>
                    <measurement group_id="B16" value="38"/>
                    <measurement group_id="B17" value="46"/>
                    <measurement group_id="B18" value="45"/>
                    <measurement group_id="B19" value="726"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="43"/>
                    <measurement group_id="B4" value="42"/>
                    <measurement group_id="B5" value="36"/>
                    <measurement group_id="B6" value="35"/>
                    <measurement group_id="B7" value="33"/>
                    <measurement group_id="B8" value="27"/>
                    <measurement group_id="B9" value="38"/>
                    <measurement group_id="B10" value="37"/>
                    <measurement group_id="B11" value="32"/>
                    <measurement group_id="B12" value="37"/>
                    <measurement group_id="B13" value="40"/>
                    <measurement group_id="B14" value="36"/>
                    <measurement group_id="B15" value="27"/>
                    <measurement group_id="B16" value="34"/>
                    <measurement group_id="B17" value="30"/>
                    <measurement group_id="B18" value="33"/>
                    <measurement group_id="B19" value="637"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="4"/>
                    <measurement group_id="B6" value="6"/>
                    <measurement group_id="B7" value="17"/>
                    <measurement group_id="B8" value="19"/>
                    <measurement group_id="B9" value="8"/>
                    <measurement group_id="B10" value="11"/>
                    <measurement group_id="B11" value="15"/>
                    <measurement group_id="B12" value="10"/>
                    <measurement group_id="B13" value="11"/>
                    <measurement group_id="B14" value="12"/>
                    <measurement group_id="B15" value="13"/>
                    <measurement group_id="B16" value="15"/>
                    <measurement group_id="B17" value="12"/>
                    <measurement group_id="B18" value="13"/>
                    <measurement group_id="B19" value="179"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="75"/>
                    <measurement group_id="B4" value="75"/>
                    <measurement group_id="B5" value="71"/>
                    <measurement group_id="B6" value="69"/>
                    <measurement group_id="B7" value="59"/>
                    <measurement group_id="B8" value="54"/>
                    <measurement group_id="B9" value="68"/>
                    <measurement group_id="B10" value="65"/>
                    <measurement group_id="B11" value="61"/>
                    <measurement group_id="B12" value="63"/>
                    <measurement group_id="B13" value="64"/>
                    <measurement group_id="B14" value="59"/>
                    <measurement group_id="B15" value="64"/>
                    <measurement group_id="B16" value="55"/>
                    <measurement group_id="B17" value="63"/>
                    <measurement group_id="B18" value="61"/>
                    <measurement group_id="B19" value="1171"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="2"/>
                    <measurement group_id="B14" value="3"/>
                    <measurement group_id="B15" value="1"/>
                    <measurement group_id="B16" value="2"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="4"/>
                    <measurement group_id="B19" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="3"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="4"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="1"/>
                    <measurement group_id="B17" value="1"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="2"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="8"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="23"/>
                    <measurement group_id="B8" value="18"/>
                    <measurement group_id="B9" value="24"/>
                    <measurement group_id="B10" value="18"/>
                    <measurement group_id="B11" value="23"/>
                    <measurement group_id="B12" value="19"/>
                    <measurement group_id="B13" value="7"/>
                    <measurement group_id="B14" value="8"/>
                    <measurement group_id="B15" value="8"/>
                    <measurement group_id="B16" value="5"/>
                    <measurement group_id="B17" value="6"/>
                    <measurement group_id="B18" value="10"/>
                    <measurement group_id="B19" value="203"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="72"/>
                    <measurement group_id="B5" value="63"/>
                    <measurement group_id="B6" value="65"/>
                    <measurement group_id="B7" value="48"/>
                    <measurement group_id="B8" value="51"/>
                    <measurement group_id="B9" value="46"/>
                    <measurement group_id="B10" value="53"/>
                    <measurement group_id="B11" value="52"/>
                    <measurement group_id="B12" value="51"/>
                    <measurement group_id="B13" value="69"/>
                    <measurement group_id="B14" value="64"/>
                    <measurement group_id="B15" value="70"/>
                    <measurement group_id="B16" value="66"/>
                    <measurement group_id="B17" value="69"/>
                    <measurement group_id="B18" value="68"/>
                    <measurement group_id="B19" value="1109"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="2"/>
                    <measurement group_id="B5" value="2"/>
                    <measurement group_id="B6" value="4"/>
                    <measurement group_id="B7" value="2"/>
                    <measurement group_id="B8" value="1"/>
                    <measurement group_id="B9" value="2"/>
                    <measurement group_id="B10" value="1"/>
                    <measurement group_id="B11" value="1"/>
                    <measurement group_id="B12" value="1"/>
                    <measurement group_id="B13" value="1"/>
                    <measurement group_id="B14" value="1"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="0"/>
                    <measurement group_id="B8" value="0"/>
                    <measurement group_id="B9" value="0"/>
                    <measurement group_id="B10" value="0"/>
                    <measurement group_id="B11" value="0"/>
                    <measurement group_id="B12" value="0"/>
                    <measurement group_id="B13" value="0"/>
                    <measurement group_id="B14" value="0"/>
                    <measurement group_id="B15" value="0"/>
                    <measurement group_id="B16" value="0"/>
                    <measurement group_id="B17" value="0"/>
                    <measurement group_id="B18" value="0"/>
                    <measurement group_id="B19" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 10-18 Years</title>
        <description>A solicited reaction (SR) is an adverse event (AE) that is prelisted in the electronic Case Report Form (eCRF) and considered to be related to vaccination. An SR is therefore an adverse drug reaction (ADR) observed and reported under the conditions (nature &amp; onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and solicited systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
        <time_frame>Within 7 days after vaccination</time_frame>
        <population>Safety analysis set that was defined as those participants who had received study vaccine. All participants had their safety analyzed according to the vaccine they actually received. Here, &quot;number analyzed&quot;= number of participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>Adolescents: SP0173 Formulation 1</title>
            <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap) vaccine.</description>
          </group>
          <group group_id="O2">
            <title>Adolescents: SP0173 Formulation 2</title>
            <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O3">
            <title>Adolescents: SP0173 Formulation 3</title>
            <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Adolescents: SP0173 Formulation 4</title>
            <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O5">
            <title>Adolescents: Adacel®</title>
            <description>Healthy participants aged 10–18 years received Adacel®.</description>
          </group>
          <group group_id="O6">
            <title>Adolescents: Boostrix®</title>
            <description>Healthy participants aged 10–18 years received Boostrix®.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 10-18 Years</title>
          <description>A solicited reaction (SR) is an adverse event (AE) that is prelisted in the electronic Case Report Form (eCRF) and considered to be related to vaccination. An SR is therefore an adverse drug reaction (ADR) observed and reported under the conditions (nature &amp; onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and solicited systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
          <population>Safety analysis set that was defined as those participants who had received study vaccine. All participants had their safety analyzed according to the vaccine they actually received. Here, &quot;number analyzed&quot;= number of participants with available data for each specified category.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="79"/>
                <count group_id="O2" value="71"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="77"/>
                <count group_id="O5" value="75"/>
                <count group_id="O6" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Injection site pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59"/>
                    <measurement group_id="O2" value="51"/>
                    <measurement group_id="O3" value="50"/>
                    <measurement group_id="O4" value="49"/>
                    <measurement group_id="O5" value="59"/>
                    <measurement group_id="O6" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site erythema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="10"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="4"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="8"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Upper limb edema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="74"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45"/>
                    <measurement group_id="O2" value="41"/>
                    <measurement group_id="O3" value="49"/>
                    <measurement group_id="O4" value="46"/>
                    <measurement group_id="O5" value="48"/>
                    <measurement group_id="O6" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extensive limb swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="79"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="77"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="75"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="25"/>
                    <measurement group_id="O5" value="20"/>
                    <measurement group_id="O6" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaise</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="18"/>
                    <measurement group_id="O5" value="12"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="78"/>
                    <count group_id="O2" value="69"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="74"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="73"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="38"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="52"/>
                    <measurement group_id="O6" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 19-64 Years</title>
        <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
        <time_frame>Within 7 days after vaccination</time_frame>
        <population>Analysis was performed on safety analysis set. Here, &quot;number analyzed&quot;=number of participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>Adults: SP0173 Formulation 1</title>
            <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O2">
            <title>Adults: SP0173 Formulation 2</title>
            <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O3">
            <title>Adults: SP0173 Formulation 3</title>
            <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Adults: SP0173 Formulation 4</title>
            <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O5">
            <title>Adults: Adacel®</title>
            <description>Healthy participants aged 19–64 years received Adacel®.</description>
          </group>
          <group group_id="O6">
            <title>Adults: Boostrix®</title>
            <description>Healthy participants aged 19–64 years received Boostrix®.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged 19-64 Years</title>
          <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
          <population>Analysis was performed on safety analysis set. Here, &quot;number analyzed&quot;=number of participants with available data for each specified category.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="73"/>
                <count group_id="O3" value="76"/>
                <count group_id="O4" value="76"/>
                <count group_id="O5" value="76"/>
                <count group_id="O6" value="72"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Injection site pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="49"/>
                    <measurement group_id="O4" value="42"/>
                    <measurement group_id="O5" value="49"/>
                    <measurement group_id="O6" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site erythema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="5"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="4"/>
                    <measurement group_id="O4" value="1"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Upper limb edema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="71"/>
                    <count group_id="O2" value="67"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="69"/>
                    <count group_id="O5" value="71"/>
                    <count group_id="O6" value="67"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="37"/>
                    <measurement group_id="O3" value="41"/>
                    <measurement group_id="O4" value="37"/>
                    <measurement group_id="O5" value="35"/>
                    <measurement group_id="O6" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extensive limb swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="76"/>
                    <count group_id="O4" value="76"/>
                    <count group_id="O5" value="76"/>
                    <count group_id="O6" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="71"/>
                    <count group_id="O2" value="68"/>
                    <count group_id="O3" value="72"/>
                    <count group_id="O4" value="70"/>
                    <count group_id="O5" value="71"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="2"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="19"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="19"/>
                    <measurement group_id="O6" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaise</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="16"/>
                    <measurement group_id="O4" value="19"/>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="73"/>
                    <count group_id="O2" value="71"/>
                    <count group_id="O3" value="73"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="36"/>
                    <measurement group_id="O5" value="39"/>
                    <measurement group_id="O6" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged &gt;=65 Years</title>
        <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
        <time_frame>Within 7 days after vaccination</time_frame>
        <population>Analysis was performed on safety analysis set. Here, &quot;number analyzed&quot;=number of participants with available data for each specified category.</population>
        <group_list>
          <group group_id="O1">
            <title>Older Adults: SP0173 Formulation 1</title>
            <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O2">
            <title>Older Adults: SP0173 Formulation 2</title>
            <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O3">
            <title>Older Adults: SP0173 Formulation 3</title>
            <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O4">
            <title>Older Adults: SP0173 Formulation 4</title>
            <description>Healthy participants aged &gt;=65 years received a single dose of the SP0173 Tdap vaccine.</description>
          </group>
          <group group_id="O5">
            <title>Older Adults: Adacel®</title>
            <description>Healthy participants aged &gt;=65 years received Adacel®.</description>
          </group>
          <group group_id="O6">
            <title>Older Adults: Boostrix®</title>
            <description>Healthy participants aged &gt;=65 years received Boostrix®.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Solicited Injections Site or Systemic Reactions Following Vaccination at Day 0: Aged &gt;=65 Years</title>
          <description>An SR is an AE that is prelisted in the eCRF and considered to be related to vaccination. An SR is therefore an ADR observed and reported under the conditions (nature and onset) prelisted (i.e., solicited) in the eCRF. An unsolicited AE is an observed AE that does not fulfill the conditions prelisted in the eCRF in terms of symptom and/or onset post-vaccination. Solicited injection site reactions: Pain, Erythema, Swelling, Upper limb edema, Extensive limb swelling and systemic reactions: Fever, Headache, Malaise, Myalgia. Number of participants with at least one solicited injection site reactions and systemic reactions were reported.</description>
          <population>Analysis was performed on safety analysis set. Here, &quot;number analyzed&quot;=number of participants with available data for each specified category.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="73"/>
                <count group_id="O3" value="78"/>
                <count group_id="O4" value="72"/>
                <count group_id="O5" value="76"/>
                <count group_id="O6" value="78"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Injection site pain</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="78"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="34"/>
                    <measurement group_id="O3" value="34"/>
                    <measurement group_id="O4" value="34"/>
                    <measurement group_id="O5" value="28"/>
                    <measurement group_id="O6" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site erythema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="78"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="3"/>
                    <measurement group_id="O6" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Injection site swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="78"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="75"/>
                    <count group_id="O6" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                    <measurement group_id="O3" value="6"/>
                    <measurement group_id="O4" value="2"/>
                    <measurement group_id="O5" value="1"/>
                    <measurement group_id="O6" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Upper limb edema</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="75"/>
                    <count group_id="O2" value="70"/>
                    <count group_id="O3" value="75"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="74"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="43"/>
                    <measurement group_id="O3" value="36"/>
                    <measurement group_id="O4" value="38"/>
                    <measurement group_id="O5" value="32"/>
                    <measurement group_id="O6" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Extensive limb swelling</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="78"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="76"/>
                    <count group_id="O6" value="78"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Fever</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="76"/>
                    <count group_id="O2" value="72"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="71"/>
                    <count group_id="O5" value="72"/>
                    <count group_id="O6" value="74"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="0"/>
                    <measurement group_id="O5" value="0"/>
                    <measurement group_id="O6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Headache</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="78"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="74"/>
                    <count group_id="O6" value="77"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="10"/>
                    <measurement group_id="O3" value="20"/>
                    <measurement group_id="O4" value="12"/>
                    <measurement group_id="O5" value="11"/>
                    <measurement group_id="O6" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Malaise</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="74"/>
                    <count group_id="O6" value="77"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="12"/>
                    <measurement group_id="O3" value="14"/>
                    <measurement group_id="O4" value="9"/>
                    <measurement group_id="O5" value="8"/>
                    <measurement group_id="O6" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Myalgia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="77"/>
                    <count group_id="O2" value="73"/>
                    <count group_id="O3" value="77"/>
                    <count group_id="O4" value="72"/>
                    <count group_id="O5" value="74"/>
                    <count group_id="O6" value="77"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="21"/>
                    <measurement group_id="O3" value="30"/>
                    <measurement group_id="O4" value="23"/>
                    <measurement group_id="O5" value="23"/>
                    <measurement group_id="O6" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Non-serious AEs were collected from Day 0 to Day 7 (SRs) or Day 30 (unsolicited AEs) after vaccination. Serious AEs were collected from Day 0 up to Month 6 after vaccination.</time_frame>
      <desc>A SR was an AE that was prelisted (i.e. solicited) in the eCRF and considered to be related to vaccination (ADR). An unsolicited AE was an observed AE that did not fulfill the conditions prelisted in the eCRF (i.e., solicited) in terms of symptom and/or onset post-vaccination. AEs were summarized in the safety analysis set.</desc>
      <group_list>
        <group group_id="E1">
          <title>Adolescents: SP0173 Formulation 1</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed (Tdap) vaccine.</description>
        </group>
        <group group_id="E2">
          <title>Adolescents: SP0173 Formulation 2</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E3">
          <title>Adolescents: SP0173 Formulation 3</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E4">
          <title>Adolescents: SP0173 Formulation 4</title>
          <description>Healthy participants aged 10–18 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E5">
          <title>Adolescents: Adacel®</title>
          <description>Healthy participants aged 10–18 years received Adacel®.</description>
        </group>
        <group group_id="E6">
          <title>Adolescents: Boostrix®</title>
          <description>Healthy participants aged 10–18 years received Boostrix®.</description>
        </group>
        <group group_id="E7">
          <title>Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E8">
          <title>Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E9">
          <title>Adults: SP0173 Formulation 3</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E10">
          <title>Adults: SP0173 Formulation 4</title>
          <description>Healthy participants aged 19–64 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E11">
          <title>Adults: Adacel®</title>
          <description>Healthy participants aged 19–64 years received Adacel®.</description>
        </group>
        <group group_id="E12">
          <title>Adults: Boostrix®</title>
          <description>Healthy participants aged 19–64 years received Boostrix®.</description>
        </group>
        <group group_id="E13">
          <title>Older Adults: SP0173 Formulation 1</title>
          <description>Healthy participants aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E14">
          <title>Older Adults: SP0173 Formulation 2</title>
          <description>Healthy participants aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E15">
          <title>Older Adults: SP0173 Formulation 3</title>
          <description>Healthy participants aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E16">
          <title>Older Adults: SP0173 Formulation 4</title>
          <description>Healthy participants aged &gt;= 65 years received a single dose of the SP0173 Tdap vaccine.</description>
        </group>
        <group group_id="E17">
          <title>Older Adults: Adacel®</title>
          <description>Healthy participants aged &gt;= 65 years received Adacel®.</description>
        </group>
        <group group_id="E18">
          <title>Older Adults: Boostrix®</title>
          <description>Healthy participants aged &gt;= 65 years received Boostrix®.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 18.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="77"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="73"/>
                <counts group_id="E15" subjects_affected="4" subjects_at_risk="78"/>
                <counts group_id="E16" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E17" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E18" subjects_affected="2" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Coronary Artery Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Device Dislocation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Drug Withdrawal Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Drug Hypersensitivity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis Perforated</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Humerus Fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Laceration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Breast Cancer Recurrent</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Embolic Cerebral Infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Transient Ischaemic Attack</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Post-Traumatic Stress Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Kidney Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Aortic Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="79"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="71"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 18.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="71" subjects_at_risk="79"/>
                <counts group_id="E2" subjects_affected="64" subjects_at_risk="71"/>
                <counts group_id="E3" subjects_affected="67" subjects_at_risk="77"/>
                <counts group_id="E4" subjects_affected="68" subjects_at_risk="77"/>
                <counts group_id="E5" subjects_affected="71" subjects_at_risk="75"/>
                <counts group_id="E6" subjects_affected="66" subjects_at_risk="75"/>
                <counts group_id="E7" subjects_affected="52" subjects_at_risk="76"/>
                <counts group_id="E8" subjects_affected="53" subjects_at_risk="73"/>
                <counts group_id="E9" subjects_affected="67" subjects_at_risk="76"/>
                <counts group_id="E10" subjects_affected="54" subjects_at_risk="76"/>
                <counts group_id="E11" subjects_affected="62" subjects_at_risk="76"/>
                <counts group_id="E12" subjects_affected="50" subjects_at_risk="72"/>
                <counts group_id="E13" subjects_affected="53" subjects_at_risk="77"/>
                <counts group_id="E14" subjects_affected="60" subjects_at_risk="73"/>
                <counts group_id="E15" subjects_affected="58" subjects_at_risk="78"/>
                <counts group_id="E16" subjects_affected="53" subjects_at_risk="72"/>
                <counts group_id="E17" subjects_affected="49" subjects_at_risk="76"/>
                <counts group_id="E18" subjects_affected="56" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="79"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="71"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="77"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="77"/>
                <counts group_id="E5" events="3" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Change In Limb Circumference</sub_title>
                <counts group_id="E1" events="45" subjects_affected="45" subjects_at_risk="79"/>
                <counts group_id="E2" events="41" subjects_affected="41" subjects_at_risk="71"/>
                <counts group_id="E3" events="49" subjects_affected="49" subjects_at_risk="77"/>
                <counts group_id="E4" events="46" subjects_affected="46" subjects_at_risk="77"/>
                <counts group_id="E5" events="48" subjects_affected="48" subjects_at_risk="75"/>
                <counts group_id="E6" events="33" subjects_affected="33" subjects_at_risk="75"/>
                <counts group_id="E7" events="28" subjects_affected="28" subjects_at_risk="76"/>
                <counts group_id="E8" events="37" subjects_affected="37" subjects_at_risk="73"/>
                <counts group_id="E9" events="41" subjects_affected="41" subjects_at_risk="76"/>
                <counts group_id="E10" events="37" subjects_affected="37" subjects_at_risk="76"/>
                <counts group_id="E11" events="35" subjects_affected="35" subjects_at_risk="76"/>
                <counts group_id="E12" events="31" subjects_affected="31" subjects_at_risk="72"/>
                <counts group_id="E13" events="38" subjects_affected="38" subjects_at_risk="77"/>
                <counts group_id="E14" events="43" subjects_affected="43" subjects_at_risk="73"/>
                <counts group_id="E15" events="36" subjects_affected="36" subjects_at_risk="78"/>
                <counts group_id="E16" events="38" subjects_affected="38" subjects_at_risk="72"/>
                <counts group_id="E17" events="32" subjects_affected="32" subjects_at_risk="76"/>
                <counts group_id="E18" events="40" subjects_affected="40" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Injection Site Erythema</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="79"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E3" events="10" subjects_affected="10" subjects_at_risk="77"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="77"/>
                <counts group_id="E5" events="4" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E7" events="2" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="5" subjects_affected="5" subjects_at_risk="76"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E17" events="3" subjects_affected="3" subjects_at_risk="76"/>
                <counts group_id="E18" events="1" subjects_affected="1" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Injection Site Pain</sub_title>
                <counts group_id="E1" events="59" subjects_affected="59" subjects_at_risk="79"/>
                <counts group_id="E2" events="51" subjects_affected="51" subjects_at_risk="71"/>
                <counts group_id="E3" events="50" subjects_affected="50" subjects_at_risk="77"/>
                <counts group_id="E4" events="49" subjects_affected="49" subjects_at_risk="77"/>
                <counts group_id="E5" events="59" subjects_affected="59" subjects_at_risk="75"/>
                <counts group_id="E6" events="48" subjects_affected="48" subjects_at_risk="75"/>
                <counts group_id="E7" events="38" subjects_affected="38" subjects_at_risk="76"/>
                <counts group_id="E8" events="34" subjects_affected="34" subjects_at_risk="73"/>
                <counts group_id="E9" events="49" subjects_affected="49" subjects_at_risk="76"/>
                <counts group_id="E10" events="42" subjects_affected="42" subjects_at_risk="76"/>
                <counts group_id="E11" events="49" subjects_affected="49" subjects_at_risk="76"/>
                <counts group_id="E12" events="35" subjects_affected="35" subjects_at_risk="72"/>
                <counts group_id="E13" events="22" subjects_affected="22" subjects_at_risk="77"/>
                <counts group_id="E14" events="34" subjects_affected="34" subjects_at_risk="73"/>
                <counts group_id="E15" events="34" subjects_affected="34" subjects_at_risk="78"/>
                <counts group_id="E16" events="34" subjects_affected="34" subjects_at_risk="72"/>
                <counts group_id="E17" events="28" subjects_affected="28" subjects_at_risk="76"/>
                <counts group_id="E18" events="25" subjects_affected="25" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Injection Site Swelling</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="79"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E3" events="8" subjects_affected="8" subjects_at_risk="77"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E5" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E6" events="4" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E8" events="3" subjects_affected="3" subjects_at_risk="73"/>
                <counts group_id="E9" events="4" subjects_affected="4" subjects_at_risk="76"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E11" events="3" subjects_affected="3" subjects_at_risk="76"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E13" events="1" subjects_affected="1" subjects_at_risk="77"/>
                <counts group_id="E14" events="6" subjects_affected="6" subjects_at_risk="73"/>
                <counts group_id="E15" events="6" subjects_affected="6" subjects_at_risk="78"/>
                <counts group_id="E16" events="2" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E17" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="79"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="71"/>
                <counts group_id="E3" events="14" subjects_affected="14" subjects_at_risk="77"/>
                <counts group_id="E4" events="18" subjects_affected="18" subjects_at_risk="77"/>
                <counts group_id="E5" events="12" subjects_affected="12" subjects_at_risk="75"/>
                <counts group_id="E6" events="17" subjects_affected="17" subjects_at_risk="75"/>
                <counts group_id="E7" events="18" subjects_affected="18" subjects_at_risk="76"/>
                <counts group_id="E8" events="9" subjects_affected="9" subjects_at_risk="73"/>
                <counts group_id="E9" events="16" subjects_affected="16" subjects_at_risk="76"/>
                <counts group_id="E10" events="19" subjects_affected="19" subjects_at_risk="76"/>
                <counts group_id="E11" events="23" subjects_affected="23" subjects_at_risk="76"/>
                <counts group_id="E12" events="15" subjects_affected="15" subjects_at_risk="72"/>
                <counts group_id="E13" events="6" subjects_affected="6" subjects_at_risk="77"/>
                <counts group_id="E14" events="12" subjects_affected="12" subjects_at_risk="73"/>
                <counts group_id="E15" events="14" subjects_affected="14" subjects_at_risk="78"/>
                <counts group_id="E16" events="9" subjects_affected="9" subjects_at_risk="72"/>
                <counts group_id="E17" events="8" subjects_affected="8" subjects_at_risk="76"/>
                <counts group_id="E18" events="6" subjects_affected="6" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Pharyngitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="79"/>
                <counts group_id="E2" events="10" subjects_affected="7" subjects_at_risk="71"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="77"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="77"/>
                <counts group_id="E5" events="5" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E6" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Pharyngitis Streptococcal</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="79"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E3" events="7" subjects_affected="5" subjects_at_risk="77"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="77"/>
                <counts group_id="E5" events="2" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E6" events="5" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E9" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Viral Pharyngitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="79"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E3" events="3" subjects_affected="2" subjects_at_risk="77"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="77"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E6" events="1" subjects_affected="1" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E9" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E10" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="0" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" events="42" subjects_affected="42" subjects_at_risk="79"/>
                <counts group_id="E2" events="35" subjects_affected="35" subjects_at_risk="71"/>
                <counts group_id="E3" events="38" subjects_affected="38" subjects_at_risk="77"/>
                <counts group_id="E4" events="42" subjects_affected="42" subjects_at_risk="77"/>
                <counts group_id="E5" events="52" subjects_affected="52" subjects_at_risk="75"/>
                <counts group_id="E6" events="38" subjects_affected="38" subjects_at_risk="75"/>
                <counts group_id="E7" events="32" subjects_affected="32" subjects_at_risk="76"/>
                <counts group_id="E8" events="29" subjects_affected="29" subjects_at_risk="73"/>
                <counts group_id="E9" events="35" subjects_affected="35" subjects_at_risk="76"/>
                <counts group_id="E10" events="36" subjects_affected="36" subjects_at_risk="76"/>
                <counts group_id="E11" events="39" subjects_affected="39" subjects_at_risk="76"/>
                <counts group_id="E12" events="28" subjects_affected="28" subjects_at_risk="72"/>
                <counts group_id="E13" events="12" subjects_affected="12" subjects_at_risk="77"/>
                <counts group_id="E14" events="21" subjects_affected="21" subjects_at_risk="73"/>
                <counts group_id="E15" events="31" subjects_affected="31" subjects_at_risk="78"/>
                <counts group_id="E16" events="23" subjects_affected="23" subjects_at_risk="72"/>
                <counts group_id="E17" events="23" subjects_affected="23" subjects_at_risk="76"/>
                <counts group_id="E18" events="18" subjects_affected="18" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="25" subjects_affected="23" subjects_at_risk="79"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="71"/>
                <counts group_id="E3" events="21" subjects_affected="19" subjects_at_risk="77"/>
                <counts group_id="E4" events="26" subjects_affected="25" subjects_at_risk="77"/>
                <counts group_id="E5" events="22" subjects_affected="22" subjects_at_risk="75"/>
                <counts group_id="E6" events="30" subjects_affected="29" subjects_at_risk="75"/>
                <counts group_id="E7" events="16" subjects_affected="16" subjects_at_risk="76"/>
                <counts group_id="E8" events="11" subjects_affected="11" subjects_at_risk="73"/>
                <counts group_id="E9" events="19" subjects_affected="19" subjects_at_risk="76"/>
                <counts group_id="E10" events="19" subjects_affected="19" subjects_at_risk="76"/>
                <counts group_id="E11" events="19" subjects_affected="19" subjects_at_risk="76"/>
                <counts group_id="E12" events="21" subjects_affected="19" subjects_at_risk="72"/>
                <counts group_id="E13" events="6" subjects_affected="6" subjects_at_risk="77"/>
                <counts group_id="E14" events="10" subjects_affected="10" subjects_at_risk="73"/>
                <counts group_id="E15" events="20" subjects_affected="20" subjects_at_risk="78"/>
                <counts group_id="E16" events="12" subjects_affected="12" subjects_at_risk="72"/>
                <counts group_id="E17" events="11" subjects_affected="11" subjects_at_risk="76"/>
                <counts group_id="E18" events="15" subjects_affected="14" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="79"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="71"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="77"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="77"/>
                <counts group_id="E5" events="3" subjects_affected="2" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E8" events="1" subjects_affected="1" subjects_at_risk="73"/>
                <counts group_id="E9" events="2" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E11" events="2" subjects_affected="2" subjects_at_risk="76"/>
                <counts group_id="E12" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E16" events="1" subjects_affected="1" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="2" subjects_affected="2" subjects_at_risk="78"/>
              </event>
              <event>
                <sub_title>Oropharyngeal Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="79"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="71"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="77"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="77"/>
                <counts group_id="E5" events="5" subjects_affected="4" subjects_at_risk="75"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E7" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E8" events="2" subjects_affected="2" subjects_at_risk="73"/>
                <counts group_id="E9" events="5" subjects_affected="4" subjects_at_risk="76"/>
                <counts group_id="E10" events="1" subjects_affected="1" subjects_at_risk="76"/>
                <counts group_id="E11" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E12" events="2" subjects_affected="2" subjects_at_risk="72"/>
                <counts group_id="E13" events="0" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E14" events="0" subjects_affected="0" subjects_at_risk="73"/>
                <counts group_id="E15" events="1" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E16" events="0" subjects_affected="0" subjects_at_risk="72"/>
                <counts group_id="E17" events="0" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E18" events="0" subjects_affected="0" subjects_at_risk="78"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Sponsor must have the opportunity to review at least 60 days prior to submission for publication or presentation. If review indicates that potentially patentable subject matter would be disclosed, publication or public disclosure may be delayed for a maximum of an additional 60 days to allow for filing the necessary patent applications.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Trial Transparency Team</name_or_title>
      <organization>Sanofi Pasteur</organization>
      <phone>800-633-1610 ext 1#</phone>
      <email>Contact-US@sanofi.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

